Resources For:

Scientist Profiles

Sally L. Glaser, Ph.D.
CEO and Research Scientist, Northern California Cancer Center
Director, Greater Bay Area Cancer Registry
Consulting Associate Professor, Division of Epidemiology, Dept. of Health Research & Policy, Stanford University School of Medicine
Member, Stanford Cancer Center

2201 Walnut Avenue, Suite 300
Fremont, California 94538-2334
E-mail: sglaser@nccc.org
Phone: 510-608-5042
Fax: 510-608-5085

Research Interests:

Using registry data to document and understand patterns of cancer incidence and survival
Understanding factors leading to the development of and survival after Hodgkin lymphoma
Understanding factors leading to the development of and survival after breast cancer
Understanding how Epstein-Barr virus is related to the development of cancers

Hodgkin lymphoma: Dr. Glaser has conducted numerous descriptive studies in the epidemiology of Hodgkin lymphoma (HL). Her analytic work includes a case-control study of reproductive factors for HL in women that yielded analyses of numerous additional risk factors and pertinent methodologic issues. With collaborators, Glaser has evaluated the reliability of Epstein-Barr virus (EBV) detection assays, generating interpretation guidelines to minimize this variation. Her current interests in HL involve genetic determinants of risk and their interaction with environmental factors.

Breast cancer: Dr. Glaser's analytic studies have focused primarily on immune function modulators. These include a population-based study of EBV and risk of breast cancer, and subsequent work with collaborators to develop a comprehensive panel of novel EBV assays to apply to a representative group of breast tumors. In addition, she has pursued the hypothesis that racial/ethnic variation in HL genotypes explains some portion of racial/ethnic variation in breast cancer incidence.

Surveillance: Within the Greater Bay Area Cancer Registry, Dr. Glaser has built a research program dedicated to the insightful use of population-based registry data to inform understanding of site-specific incidence and survival patterns in various populations, particularly those defined by race/ethnicity and socioeconomic status. New interests include evaluating population demographic trends for their impact on incidence, and examining the influence of the built environment on incidence and outcomes.

As Director of the Greater Bay Area Cancer Registry, Dr. Glaser is committed to excellence in registry function and preparing for changes facing cancer registration, including expanding data content to include more information on biomarkers, comorbidities and intermediate endpoints such as recurrence.

Selected Research Projects:

Epidemiology of EBV-defined Hodgkin lymphoma

Epstein-Barr virus and breast cancer tissues

Hodgkin Lymphoma Consortium: Pooling epidemiologic data for a research resource

Immune-function genes and racial/ethnic differences in breast cancer

All Research Projects (13)

Selected Research Publications:
Keegan THM, Clarke CA, Chang ET, Shema SJ, Glaser SL. Socioeconomic and racial/ethnic disparities in Hodgkin lymphoma survival: a population-based study. Cancer Causes Control 2009; epub.

Glaser SL, Gulley ML, Clarke CA, Keegan TH, Chang ET, Shema SJ, Craig FE, DiGiuseppe JA, Dorfman RF, Mann RB, Anton-Culver H, Ambinder RA. Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populations. Int J Cancer 2008; 123: 1499-507.

Chang ET, Keegan TH, Gomez SL, Le GM, Clarke CA, So SK, Glaser SL. The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004. Cancer 2007; May 15;109(10):2100-8.

Clarke CA, Glaser SL. Declines in breast cancer after the WHI: apparent impact of hormone therapy. CEBP 2007; 18:847-52.

Glaser SL, Clarke CA, Gomez SL, O'Malley CD, Purdie DM, West DW. Cancer surveillance research: a vital subdiscipline of cancer epidemiology. Cancer Causes Control 2005; 16:1009-19.

Glaser SL, Keegan THM, Clarke CA, Trinh MA, Dorfman RF, Mann RB, DiGiuseppe JA, Ambinder RF. Exposure to childhood infections and risk of EBV-defined Hodgkin's lymphoma in women. Int J Cancer 2005; 115:599-605.

All publications (83)

Education:

INSTITUTION AND LOCATION	DEGREE, YEAR	FIELD OF STUDY
Harvard University, Cambridge, MA	A.B., 1972	Social Relations
University of California, Berkeley, CA	M.S., 1978	Epidemiology
University of California, Berkeley, CA	Ph.D., 1984	Epidemiology
University of California, Berkeley, CA	Postdoc., 1985-86	Epidemiology
Stanford University, Stanford, CA	Postdoc., 1987-88	Epidemiology

Professional Memberships, Professional Activities, and Awards:
2009 - present: Chief Executive Officer, Northern California Cancer Center
2008-2009:       Interim Executive Director, Northern California Cancer Center
2007:                 Member, Stanford Cancer Center Survivorship Program
2006 - present: Member, Stanford Cancer Center
2005 - present: Principal Investigator, SEER program; Director, Greater Bay Area Cancer Registry
2005 - present: Member, North American Association of Central Cancer Registries
2005 - present: Consulting Associate Professor, Stanford University, Department of Health Research and Policy
2003-2005:       Co-Principal Investigator, Greater Bay Area Cancer Registry
2000-2006:       Director, Surveillance Research, Greater Bay Area Cancer Registry, Northern California Cancer Center

Web site Links:
Stanford website for Dr. Glaser:
http://med.stanford.edu/profiles/Sally_Glaser/

Back to Scientist Profiles.